Link: Novonesis will host a conference call regarding 2024 outlook and 2023 pro forma financials on March 21
Link: Novonesis will host a conference call regarding 2024 outlook and 2023 pro forma financials on March 21
See the article here: TaiMed Biologics and AcedrA BioPharmaceuticals Partner to Commercialize Trogarzo® (Ibalizumab-uiyk) in the Middle East and North Africa Region
See the rest here: RS BioTherapeutics Selected for Presentation at American Thoracic Society’s 2024 Respiratory Innovation Summit
Here is the original post: Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy for Eligible Children with Early-onset...
View post: Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics...
See the article here: Inventiva announces positive results from the Phase II, LEGEND, Proof-of-Concept study combining lanifibranor with empagliflozin in patients with...
More: Carina Biotech to Present Three Poster Presentations at AACR Annual Meeting 2024
Read the original here: PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual...
Continue reading here: Psyence Biomedical Welcomes Results of a Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin
More: Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Recent Comments